Clinical trials
Recruiting Hypertension trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Universidade Federal Fluminense | 3 |
| University of Sao Paulo | 3 |
| Instituto Dante Pazzanese de Cardiologia | 2 |
| Universidade Estadual Paulista Júlio de Mesquita Filho | 2 |
| Alnylam Pharmaceuticals | 1 |
| Boehringer Ingelheim | 1 |
| Federal University of Bahia | 1 |
| National Institute of Cardiology, Laranjeiras, Brazil | 1 |
| Raphael Mendes Ritti Dias | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 23 |
| Cardiovascular Diseases | 5 |
| Inflammation | 3 |
| Renal Insufficiency, Chronic | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Essential Hypertension | 1 |
| Heart Failure | 1 |
| Hypertension, Pregnancy-Induced | 1 |
| Menorrhagia | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.